20 Recruiting Metastatic Pancreatic Ductal Adenocarcinoma Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceTop Recruiting Metastatic Pancreatic Ductal Adenocarcinoma Studies
MK2 Inhibitor in Combination With mFOLFIRINOX for Untreated Metastatic Pancreatic Ductal Adenocarcinoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔Study of Quemliclustat and Chemotherapy Versus Placebo and Chemotherapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
📍 Research Site — Phoenix, Arizona
View Study & Checklist ➔A Study of Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy
📍 Memorial Sloan Kettering Monmouth (All protocol activities) — Middletown, New Jersey
View Study & Checklist ➔The Miami "EMPIRE" Trial - Eradication of Metastatic Pancreatic Cancer With Immuno-Radiation
📍 University of Miami — Miami, Florida
View Study & Checklist ➔Pancrelipase in People With Pancreatic Ductal Adenocarcinoma (PDAC)
📍 Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
View Study & Checklist ➔BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
📍 Georgetown Lombardi Comprehensive Cancer Center — Washington D.C., District of Columbia
View Study & Checklist ➔ONT01 and Gemcitabine/Nab-paclitaxel as Second Line Therapy for Metastatic Pancreatic Ductal Adenocarcinoma
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔A Study to Assess Intravenous (IV) Telisotuzumab Adizutecan in Combination With Fluorouracil, Folinic Acid, and Oxaliplatin (FOLFOX) Compared to Standard of Care in Adult Participants With First-Line Metastatic Pancreatic Ductal Adenocarcinoma
📍 University of Chicago Medical Center /ID# 279460 — Chicago, Illinois
View Study & Checklist ➔Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma
📍 Roswell Park Cancer Institute — Buffalo, New York
View Study & Checklist ➔Phase I Study of Cosibelimab and Balixafortide in Metastatic Pancreatic Ductal Adenocarcinoma
📍 Cedars-Sinai Cancer at SOCC — Los Angeles, California
View Study & Checklist ➔Utility of ctDNA in Early Switch of First-line mFOLFIRINOX in Metastatic Pancreatic Ductal Adenocarcinoma
📍 University of Miami — Miami, Florida
View Study & Checklist ➔